GH News and Press, Guardant Health Inc.

2024-06-11 13:45:23 ET Summary We are revisiting oncology testing company Exact Sciences Corporation today for the first time in nearly a year and a half. The shares have been cut by more than half since last summer, despite revenue growth in the low teens and strong support from ...

2024-06-06 09:50:33 ET Summary Guardant Health's stock has curled up from lows in the last six months. The FDA panel approved GH's Shield blood test, resulting in a positive announcement drift to the upside. Q1 2024 earnings showed strong growth, revised guidance, and increase...

Upgraded gene panel on tissue genomic profiling test covers 498 biomarkers, including guideline-recommended genes Operational improvements streamline workflow and shorten time to results Upgraded test covered by Medicare for comprehensive genomic profiling of all advanced solid tu...

2024-06-04 07:00:06 ET Kyle Mikson from Canaccord Genuity issued a price target of $38.00 for GH on 2024-06-04 05:20:00. The adjusted price target was set to $38.00. At the time of the announcement, GH was trading at $27.41. The overall price target consensus is at $58.2...

Data from study using Guardant360® blood test show Black patients with PIK3CA mutations in advanced breast cancer were less likely than White patients to be enrolled in clinical trials and receive targeted therapy Study is part of collaboration between Guardant Health and Multicenter...

Guardant’s Impact, Innovation, Ambition, and Success Contributed to the Recognition Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced its inclusion in the fourth-annual TIME100 Most Influential Companies list, highlighting companies making...

Studies demonstrate benefits of liquid biopsy and real-world data in targeted therapy selection and therapeutic outcomes in advanced breast cancer Interim data from PICI’s RADIOHEAD study using Guardant Infinity™ platform show correlation between epigenomic biomarkers and pa...

2024-05-27 11:34:31 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the S&P 500 sitting just a few points below setting a new all-time high, the bull market that began in 2022 is still snorting. Although a correction or even a bear market will even...

2024-05-24 21:15:02 ET Stephens analyst issues BUY recommendation for GH on May 24, 2024 05:00PM ET. The previous analyst recommendation was Buy. GH was trading at $25.52 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst rec...

2024-05-24 21:15:01 ET Piper Sandler analyst issues UNDERPERFORM recommendation for GH on May 24, 2024 05:00PM ET. The previous analyst recommendation was Underperform. GH was trading at $25.52 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...